AU7717598A - Control of immune responses by modulating activity of glycosyltransferase - Google Patents

Control of immune responses by modulating activity of glycosyltransferase

Info

Publication number
AU7717598A
AU7717598A AU77175/98A AU7717598A AU7717598A AU 7717598 A AU7717598 A AU 7717598A AU 77175/98 A AU77175/98 A AU 77175/98A AU 7717598 A AU7717598 A AU 7717598A AU 7717598 A AU7717598 A AU 7717598A
Authority
AU
Australia
Prior art keywords
immune responses
glycosyltransferase
control
modulating activity
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77175/98A
Other languages
English (en)
Inventor
Jamey D. Marth
James C Paulson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Cytel Corp
Original Assignee
University of California
Cytel Corp
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Cytel Corp, University of California Berkeley filed Critical University of California
Publication of AU7717598A publication Critical patent/AU7717598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AU77175/98A 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferase Abandoned AU7717598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4830397P 1997-05-30 1997-05-30
US60048303 1997-05-30
PCT/US1998/011260 WO1998054365A1 (en) 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferases

Publications (1)

Publication Number Publication Date
AU7717598A true AU7717598A (en) 1998-12-30

Family

ID=21953820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77175/98A Abandoned AU7717598A (en) 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferase

Country Status (7)

Country Link
US (2) US6376475B1 (enExample)
EP (1) EP1017846B1 (enExample)
JP (2) JP4451933B2 (enExample)
AT (1) ATE371041T1 (enExample)
AU (1) AU7717598A (enExample)
DE (1) DE69838298T2 (enExample)
WO (1) WO1998054365A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192914B1 (en) * 1999-09-30 2007-03-20 The Regents Of The University Of California Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
WO2001022921A2 (en) * 1999-09-30 2001-04-05 The Regents Of The University Of California Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor
CA2429625C (en) 2000-10-18 2012-05-01 Robert Sackstein Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
US20060210558A1 (en) * 2000-10-18 2006-09-21 Robert Sackstein Hematopoietic cell selectin ligand polypeptides and methods of use thereof
DK1437358T3 (da) * 2001-08-16 2007-02-05 Daiichi Asubio Pharma Co Ltd Hidtil ukendt glycolipid og medikament til autoimmune sygdomme indeholdende dette som det aktive stof
US20060074047A1 (en) * 2004-10-06 2006-04-06 Cross Alan S Method of treating inflammation with inhibitors of sialyl transferases
JP4359779B2 (ja) * 2006-01-23 2009-11-04 ソニー株式会社 音響再生装置および音響再生方法
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
CN102076865B (zh) 2008-05-02 2016-03-16 西雅图基因公司 用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物
WO2012019165A2 (en) 2010-08-05 2012-02-09 Seattle Genetics, Inc. Methods of inhibition of protein fucosylation in vivo using fucose analogs
CA2818917C (en) * 2010-12-16 2023-02-28 Basf Se Plants having increased tolerance to herbicides
JP2014159374A (ja) * 2011-05-20 2014-09-04 Nippon Nohyaku Co Ltd 作物の枯凋落葉剤組成物
AR091489A1 (es) * 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
CA2882725C (en) 2012-08-23 2021-03-09 Regents Of The University Of Minnesota Treatment of sickle cell disease and inflammatory conditions
JP2016027002A (ja) * 2012-11-16 2016-02-18 日本農薬株式会社 除草剤組成物
EP2993184B1 (en) 2013-05-02 2019-03-13 National Institute of Advanced Industrial Science and Technology Monoclonal antibody recognizing sialylated sugar chains
US10285976B2 (en) 2013-08-12 2019-05-14 The Board Of Trustees Of The Leland Stanford Junior University 4-methylumbelliferone treatment for immune modulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5288854A (en) * 1990-11-28 1994-02-22 Center For Blood Research, Inc. Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
JPH05247078A (ja) 1992-03-03 1993-09-24 Japan Tobacco Inc 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
US5453272A (en) 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
AU2828595A (en) 1994-06-15 1996-01-05 Alexion Pharmaceuticals, Inc. Methods for reducing hyperacute rejection of xenografts
AU2001296705A1 (en) * 2000-10-06 2002-04-15 The Regents Of The University Of California Blocking inflammation by inhibiting sialylation

Also Published As

Publication number Publication date
EP1017846A1 (en) 2000-07-12
DE69838298D1 (de) 2007-10-04
EP1017846A4 (en) 2004-08-11
ATE371041T1 (de) 2007-09-15
DE69838298T2 (de) 2008-05-15
WO1998054365A1 (en) 1998-12-03
US20030013636A1 (en) 2003-01-16
JP4451933B2 (ja) 2010-04-14
EP1017846B1 (en) 2007-08-22
US6376475B1 (en) 2002-04-23
JP2002528036A (ja) 2002-08-27
JP2002528037A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
AU7717598A (en) Control of immune responses by modulating activity of glycosyltransferase
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
NZ313383A (en) Cell-free synthesis of polyketides using pks (polyketide synthase)
PL328513A1 (en) Inhibitors of pharnesil transferase
AU2586895A (en) Compounds for inhibiting osteoclast-mediated bone resorption
TR199700726T1 (xx) Farnezil transferaz �nleyiciler ve m�stahzarlar�.
WO1994025612A3 (fr) Sequences de nucleotides pour le controle de l'expression de sequences d'adn dans un hote cellulaire
AU5316096A (en) Gene therapy by secretory gland expression
ES2114487B1 (es) Mezcla estabilizante sinergistica.
EP0623171A4 (en) ENZYMATIC RNA MOLECULES.
AU6451494A (en) Peptidic phosphinyloxymethyl ketones as interleukin-1beta- converting enzyme inhibitors
MX9204375A (es) Gen activador para la biosintesis de macrolidos.
YU5800A (sh) Univerzalno primenljiva krvna plazma
MX9707613A (es) Citostaticos modificados con hidratos de carbono.
AU3274793A (en) Enzymatic inverse polymerase chain reaction library mutagenesis
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
WO1998028299A3 (en) Imidazopyridazines
AU3893493A (en) Micro-organisms, preparation method therefor and uses thereof
EP0648279A4 (en) FUCOSYLTRANSFERASE ACCEPTOR.
EP1048641A4 (en) APOPTOSIS-TIMER
ZA967321B (en) Staurosporin biosynthesis gene clusters.
AU7296096A (en) Low-nitrate, manganese-free zinc phosphatization
ZA961564B (en) Methods of inhibiting ovarian cancer.
AU4590089A (en) Inhibin isolated from ovarian follicular fluid
AU1436292A (en) Transglutaminase enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase